CrystalGenomics, ProQuest create new drug-development JV, Palkion

February 26, 2008 | David P. Hamilton | Comments | |

See our story about Emeryville, Calif.-based CrystalGenomics and its new JV in today’s daily briefing at VentureBeat Life Sciences.

Next Story: Updated: Is Take-Two distracting Electronic Arts from opportunities like Facebook gaming?
Previous Story: TidalTV to create professionally produced video content on the web, secures $15M

Bookmark and Share

Photo of David P. Hamilton

About the Author, David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.